9:00am - 5:00pm
Our Opening Hours Mon. - Fri.
1.800.799.2234
Call Us For Free Consultation
Phase I Dose Escalation Study of BAY94-9343 Given by Intravenous Infusion Every 3 Weeks in Japanese Subjects With Advanced Malignancies...
Continue readingPhase I Study of OSI-930 and Erlotinib in Cancer Tumors...
Continue readingA Dose Escalation Study to Assess Safety of GSK2256098 (FAK Inhibitor) in Combination With Trametinib (MEK Inhibitor) in Subjects With Advanced Solid Tumors...
Continue readingLEE011 for Patients With CDK4/6 Pathway Activated Tumors (SIGNATURE)...
Continue readingRigid Thoracoscopy Versus CT-Guided Pleural Needle Biopsy...
Continue readingRapamycin With Grapefruit Juice for Advanced Malignancies...
Continue readingPhase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases...
Continue readingAn Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation...
Continue readingA Study in Non Small Cell Lung Cancer...
Continue readingInterleukin-12 in Treating Patients With Cancer in the Abdomen...
Continue reading